Strike Pharma AB is a Swedish AB based in Lund, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2020, the company has 7 employees and reported revenue of SEK 189.3k in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva läkemedelsutveckling och medicinsk forskning, sälja tillhörande tjänster och produkter samt bedriva därmed förenlig verksamhet.
In its most recent annual report (2025), Strike Pharma AB reported revenue of SEK 189.3k. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 18.5m, and the EBITDA margin stood at -9,571.7%.
At the end of 2025, equity financed 86.3% of the balance sheet, and current assets covered short-term debt 7.3 times.
Frequently asked questions
What is the Org number of Strike Pharma AB?
Strike Pharma AB is registered with Bolagsverket / SCB under Org 5592842651.
What is the revenue of Strike Pharma AB?
Strike Pharma AB reported revenue of SEK 189.3k in 2025.
How many employees does Strike Pharma AB have?
Strike Pharma AB employs 7 people as of the latest annual report.
Who is the CEO of Strike Pharma AB?
Per Göran Oskar Norlén is the CEO of Strike Pharma AB, in role since 2025.
Who is the chairman of Strike Pharma AB?
Gunnar Magnus Severus Persson chairs the board of Strike Pharma AB, in role since 2025.
Where is Strike Pharma AB headquartered?
Strike Pharma AB's registered address is Scheeletorget 1.
